MDC

(redirected from Metoprolol in Dilated Cardiomyopathy trial)
Also found in: Encyclopedia.

MDC

Metoprolol in Dilated Cardiomyopathy trial. A clinical trial that evaluated the additive effect of metoprolol on fatal and non-fatal cardiac events in patients with idiopathic dilated cardiomyopathy.

Conclusion
Seven-year survival (80% vs 62%) and transplant-free survival (68% vs 51) were significantly higher in 127 metoprolol treated cases than in 127 controls.

MDC

Cardiology A clinical trial–Metoprolol in Dilated Cardiomyopathy that evaluated the effect on M&M in Pts with idiopathic dilated cardiomyopathy treated with metoprolol, a beta blocker. See Heart failure, Metoprolol.

MDC

An abbreviation for the congenital muscular dystrophies, a group of autosomal recessive diseases characterized by significant muscular weakness and often cognitive disorders. All of the congenital muscular dystrophies first become evident in infancy. Examples include MDCs 1A-1D and Fukuyama disease.